Get the Stockscreener App
0.5051
0.90%
-0.0051
Applied Therapeutics Inc stock is traded at $0.5051, with a volume of 936.68K.
It is down -0.90% in the last 24 hours and down -11.45% over the past month.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
See More
Previous Close:
$0.5102
Open:
$0.505
24h Volume:
936.68K
Relative Volume:
0.14
Market Cap:
$59.37M
Revenue:
-
Net Income/Loss:
$-119.76M
P/E Ratio:
-0.3741
EPS:
-1.35
Net Cash Flow:
$-55.17M
1W Performance:
-4.60%
1M Performance:
-11.45%
6M Performance:
-91.94%
1Y Performance:
-93.17%
1-Day Range:
$0.50
$0.529
1-Week Range:
$0.4882
$0.59
52-Week Range:
$0.4882
$10.62
Applied Therapeutics Inc Stock (APLT) Company Profile
Name
Applied Therapeutics Inc
Sector
Industry
Phone
212-220-9226
Address
545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY
Compare APLT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
APLT
Applied Therapeutics Inc
|
0.5051 | 59.37M | 0 | -119.76M | -55.17M | -1.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.74 | 121.85B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
695.01 | 76.83B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
617.11 | 37.96B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
241.57 | 30.69B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beone Medicines Ltd Adr
|
268.04 | 29.71B | 3.32B | -860.46M | -1.04B | -8.32 |
Applied Therapeutics Inc Stock (APLT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-23-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Dec-02-24 | Downgrade | UBS | Buy → Neutral |
| Nov-29-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jul-31-24 | Initiated | William Blair | Outperform |
| Mar-26-24 | Initiated | RBC Capital Mkts | Outperform |
| Feb-22-24 | Initiated | Leerink Partners | Outperform |
| Jan-04-22 | Downgrade | Barclays | Overweight → Equal Weight |
| Aug-27-21 | Downgrade | Goldman | Neutral → Sell |
| Jun-25-21 | Resumed | Goldman | Neutral |
| Oct-08-20 | Initiated | Truist | Buy |
| Apr-22-20 | Initiated | Goldman | Buy |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Jun-10-19 | Initiated | Citigroup | Buy |
| Jun-10-19 | Initiated | Cowen | Outperform |
| Jun-10-19 | Initiated | Robert W. Baird | Outperform |
View All
Applied Therapeutics Inc Stock (APLT) Latest News
APLT stock touches 52-week low at $0.54 amid sharp annual decline By Investing.com - Investing.com South Africa
APLT stock touches 52-week low at $0.54 amid sharp annual decline - Investing.com
Applied Therapeutics Inc (APLT) At $0.58 Is Well Worth Your Time - Stocks Register
Applied Therapeutics, Inc. (NASDAQ:APLT) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
2025-02-18 | Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics, Inc. LawsuitAPLT | NDAQ:APLT | Press Release - Stockhouse Publishing
Shareholders of Applied Therapeutics, Inc. Should Contact The Gross Law Firm Before February 18, 2025 to Discuss Your RightsAPLT - PR Newswire
Applied Therapeutics, Inc. Sued for Securities Law - GlobeNewswire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics - Business Wire
DEADLINE ALERT for APLT and KSPI: The Law Offices of Frank - GlobeNewswire
2025-02-18 | Investors in Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your RightsAPLT | NDAQ:APLT | Press Release - Stockhouse Publishing
Class Action Filed Against Applied Therapeutics, Inc. (APLT)February 18, 2025 Deadline to JoinContact Levi & Korsinsky - Lelezard
2025-02-18 | Class Action Filed Against Applied Therapeutics, Inc. (APLT)February 18, 2025 Deadline to JoinContact Levi & Korsinsky | NDAQ:APLT | Press Release - Stockhouse Publishing
Levi & Korsinsky Notifies APLT Investors of Class Action Lead Plaintiff Deadline: February 18, 2025 - The Octant
Deadline on February 18th coming up in Lawsuit for Investors in Applied Therapeutics, Inc. (NASDAQ: APLT) - openPR
2025-02-17 | Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Applied Therapeutics, Inc. (APLT) Shareholders | NDAQ:APLT | Press Release - Stockhouse Publishing
APLT DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. ... - The Bakersfield Californian
APLT DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - GlobeNewswire Inc.
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics - Stockhouse Publishing
2025-02-17 | Class Action Filed Against Applied Therapeutics, Inc. (APLT)February 18, 2025 Deadline to JoinContact Levi & Korsinsky | NDAQ:APLT | Press Release - Stockhouse Publishing
INVESTOR DEADLINE TOMORROW: Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitAPLT - PR Newswire
APLT COURT NEWS: Applied Therapeutics has been Sued for - GlobeNewswire
2025-02-16 | Shareholders that lost money on Applied Therapeutics, Inc.(APLT) should contact Levi & Korsinsky about pending Class ActionAPLT | NDAQ:APLT | Press Release - Stockhouse Publishing
APLT Deadline in 2 Days: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Filing Deadline in Class Action Lawsuit - Morningstar
2025-02-16 | Investors who Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky About Pending Class ActionAPLT | NDAQ:APLT | Press Release - Stockhouse Publishing
Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineAPLT - Stockhouse Publishing
APLT Deadline: APLT Purchasers Have Opportunity to Lead Applied Therapeutics, Inc. Securities Fraud Lawsuit - PR Newswire
2025-02-16 | INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics | NDAQ:APLT | Press Release - Stockhouse Publishing
2025-02-16 | Levi & Korsinsky Reminds Applied Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025APLT | NDAQ:APLT | Press Release - Stockhouse Publishing
APLT COURT NEWS: Applied Therapeutics has been Sued for Securities Fraud; Contact BFA Law by February 18 if You Lost Money (NASDAQ:APLT) - GlobeNewswire Inc.
Applied Therapeutics, Inc. (NASDAQ:APLT) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
APLT Deadline: Rosen Law Firm Urges Applied Therapeutics, Inc. (NASDAQ: APLT) Investors to Contact the Firm for Information About Their Rights - The Bakersfield Californian
APLT Deadline in 3 Days: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Filing Deadline in Class Action Lawsuit | FinancialContent Business Page - Financial Content
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics - StreetInsider.com
Kaplan Fox Reminds Investors of a Deadline for a Securities Fraud Class Action Lawsuit Against Applied Therapeutics (APLT) | FinancialContent Business Page - Financial Content
SG Americas Securities LLC Has $35,000 Stake in Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World
2025-02-14 | Applied Therapeutics, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationAPLT | NDAQ:APLT | Press Release - Stockhouse Publishing
Applied Therapeutics Inc [APLT] Records 50-Day SMA of $0.8519 - Knox Daily
Deadline Soon: Applied Therapeutics, Inc. (APLT) Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit - Business Wire
Kaplan Fox Alerts Investors to a Deadline for a Securities Fraud Class Action Lawsuit Against Applied Therapeutics (APLT) | FinancialContent Business Page - Financial Content
APLT Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP - GlobeNewswire
2025-02-14 | Shareholders that Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky About Pending Class ActionAPLT | NDAQ:APLT | Press Release - Stockhouse Publishing
2025-02-14 | Levi & Korsinsky Notifies Shareholders of Applied Therapeutics, Inc. (APLT) of a Class Action Lawsuit and an Upcoming Deadline | NDAQ:APLT | Press Release - Stockhouse Publishing
Applied Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Applied Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025APLT - Morningstar
2025-02-13 | Applied Therapeutics, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationAPLT | NDAQ:APLT | Press Release - Stockhouse Publishing
Applied Therapeutics, Inc. Investors: Please contact the - GlobeNewswire
Applied Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your ... - The Bakersfield Californian
APLT LAWSUIT ALERT: Levi & Korsinsky Notifies Applied - GlobeNewswire
APLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Applied Therapeutics, Inc. to Contact the Firm Today! - ACCESS Newswire
Applied Therapeutics, Inc. (APLT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
2025-02-13 | Shareholders That Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky About Pending Class ActionAPLT | NDAQ:APLT | Press Release - Stockhouse Publishing
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics - The Malaysian Reserve
Applied Therapeutics Inc Stock (APLT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Applied Therapeutics Inc Stock (APLT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Perfetti Riccardo | Chief Medical Officer |
Feb 06 '25 |
Sale |
0.61 |
86,078 |
52,508 |
900,775 |
| Chinoporos Constantine | See Remarks |
Feb 06 '25 |
Sale |
0.61 |
28,117 |
17,151 |
271,883 |
| Funtleyder Leslie D. | Chief Financial Officer |
Aug 22 '24 |
Sale |
5.83 |
13,530 |
78,880 |
277,911 |
| Perfetti Riccardo | Chief Medical Officer |
Aug 22 '24 |
Sale |
5.83 |
22,681 |
132,230 |
986,853 |
| Shendelman Shoshana | President and CEO |
Aug 13 '24 |
Sale |
6.18 |
357,423 |
2,208,874 |
4,810,430 |
| Shendelman Shoshana | President and CEO |
Aug 12 '24 |
Sale |
5.98 |
300,000 |
1,794,000 |
5,167,853 |
| Shendelman Shoshana | President and CEO |
Aug 14 '24 |
Sale |
5.93 |
119,591 |
709,175 |
4,690,839 |
1.64%
0.75%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):